AI/ML Innovations Inc. (CSE: AIML) Completes Acquisition of Quantum Sciences Ltd.

Highlights

• AI/ML Innovations acquires Quantum Sciences Ltd., a leader in AI-driven digital healthcare solutions.
• Quantum specializes in addressing critical healthcare challenges, including cardiovascular disease, neurodegenerative disorders, and metabolic conditions.
• Synergies to leverage Quantum’s medical team and AI/ML’s signal processing technologies for cardio-focused applications.

AI/ML Innovations Inc. (CSE:AIML) is pleased to announce the successful completion of the previously announced arms-length acquisition of all the issued and outstanding shares of Quantum Sciences Ltd. ("Quantum"), effective December 24, 2024. The acquisition provides AI/ML with the opportunity to expand its healthcare portfolio and leverage Quantum's cutting-edge digital healthcare solutions powered by artificial intelligence ("AI") and machine learning.

Quantum specializes in developing innovative AI-driven healthcare solutions, addressing some of the most pressing challenges in the medical field, including cardiovascular diseases, neurodegenerative disorders, and metabolic conditions. This acquisition creates synergies between AI/ML's advanced signal processing capabilities and Quantum's team of medical experts, offering new opportunities to explore and develop cardio-focused applications.

Strategic Acquisition to Strengthen Healthcare Focus
Over the last two years, Quantum's team has been working on developing a software product designed to empower patients with greater control over their health trajectory. This solution addresses the inefficiencies of the existing healthcare system, which currently lacks a centralized patient information system. Quantum’s technology aims to overcome these challenges and provide real-time data, enhancing patient outcomes and improving the healthcare experience.

Comment from Quantum’s CEO
Mark Orsmond, CEO of Quantum, expressed his enthusiasm for the acquisition, saying, “On almost a weekly basis, we are hearing and seeing how AI is transforming and redefining the medical landscape. To date, our team has been highly impressed with AI/ML's proprietary technology and its potential applications. In my view, this acquisition brings together all the key pieces necessary for a highly productive commercialization environment, including valuable access to a unique technology, experienced and skilled human resources, real-time/real-world data, and invaluable physician-led input. We are delighted to be working with Paul Duffy and his team as we move forward together.”

Quantum’s Medical Experts Join AI/ML Team
As part of the acquisition, key members of the Quantum team will join AI/ML to help advance the development of healthcare solutions. These team members include:

• Dr. Alan Rabinowitz, Quantum’s Clinical Strategist and Advisor, who brings extensive experience in cardiology. Dr. Rabinowitz was formerly the Director of the Coronary Care Unit at St. Paul's Hospital and is currently a Clinical Associate Professor in the Division of Cardiology at St. Paul's. He has held numerous advisory roles in healthcare globally and is recognized for his work in disruptive innovation and data innovation in healthcare.
• Dr. Marc W. Deyell, Quantum’s Product Development Advisor for Research & Innovation, is a leading cardiologist and Director of the Heart Rhythm Program at St. Paul's Hospital in Vancouver. Dr. Deyell is an active researcher with expertise in arrhythmias, ambulatory heart rhythm monitoring, and ventricular arrhythmias. He has completed advanced training in electrophysiology and has contributed significantly to the development of ambulatory monitoring solutions in healthcare.

AI/ML’s Path Forward
This acquisition marks a significant milestone for AI/ML Innovations as it expands its capabilities in the healthcare sector, particularly within the realms of AI and machine learning applications for digital health solutions. By combining Quantum’s AI-driven healthcare solutions with AI/ML’s expertise in signal processing, the Company is poised to develop innovative technologies that can address key healthcare challenges and significantly improve patient outcomes.

The Company is confident that this strategic acquisition will position AI/ML to play a key role in the rapidly evolving healthcare landscape, as it continues to explore new opportunities in the intersection of AI, healthcare, and patient-centric technologies.

About AI/ML Innovations Inc.
AI/ML Innovations Inc. is a technology company focused on harnessing the power of artificial intelligence and machine learning to drive innovative solutions across various sectors, including healthcare, energy, and finance. The Company is committed to exploring and advancing technologies that have the potential to transform industries and improve the quality of life for people around the world.